LAURA MAY: Open Payments
NPI 1851055776 · GOODRICH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,681 in 131 payments from 24 companies in 2025. Trend: 2023 $640 · 2024 $2,838 · 2025 $2,681
Food & beverage: $2,666Education: $16
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $603 |
| Novo Nordisk Inc | 23 | $299 |
| Corcept Therapeutics | 12 | $221 |
| Xeris Pharmaceuticals, Inc. | 14 | $215 |
| Ascendis Pharma Endocrinology Inc | 4 | $173 |
| Mannkind Corporation | 9 | $151 |
| Dexcom, Inc. | 5 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $120 |
| RECORDATI_RARE_DISEASES_INC. | 5 | $118 |
| Lilly USA, LLC | 7 | $95 |
Products named: TEPEZZA, EVENITY, Korlym, Yorvipath, Ozempic, AFREZZA, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
